cannabinoid CB2 agonists (Dompe US)

N/A

Report date: 2025/03/14 16:44:15
NME

Base Information

Drug Namecannabinoid CB2 agonists (Dompe US)
Drug Alias Namecannabinoid CB2 agonists (Dompe farmaceutici)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDompé Pharmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesDompé U.S. Inc
Inactive CompaniesDompé Pharmaceutici Spa
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A